Organizer
Evosep Biosystems
Evosep Biosystems
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
Tags
LC/MS
LC/MS/MS
HPLC
LinkedIn Logo

Evosep One in the Clinical Biochemistry Lab

RECORD | Already taken place Th, 24.2.2022
In this webinar, you can meet users from this research area and learn about their work and how they have implemented the Evosep One for routine analyses.
Go to the webinar
 Evosep Biosystems: Evosep One in the Clinical Biochemistry Lab
Evosep Biosystems: Evosep One in the Clinical Biochemistry Lab

Clinical biochemistry laboratories worldwide measure millions of samples daily from various body fluids such as blood and urine. A growing part of these analyses are performed with LC-MS/MS and especially for diagnostic niches of laboratory medicine, where superior analytical specificity is superior to immunoassays.

Why, how and when ms-based proteomics in laboratory medicine

Millions of samples are being analyzed every day to diagnose, monitor and prognose patients. In most hospitalts this is performed by a department of laboratory medicine using enzyme linked assays, radioimmunoassays and even gel-electrophoreses. More than 50% of every analyses orded at a hospital or at your own general practioneers is a protein. Currently, single assays are used to profile our patients and for decision making.

MS-based proteomics is not used in laboratory medicine for routine diagnostics. In this talk I will discuss how we have been exploring MS-based proteomics for clinical diagnostics for both common and rare diseases and finally I am eager to share our visions on how we believe MS-based proteomics may provide faster and better patient care.

Presenter: Nicolai Wewer Albrecthsen (Associate Professor at Clinical Proteomics and Metabolism, NNF Center for Protein Research, University of Copenhagen, Denmark)

Targeted Proteomics in Biomarker Development and Clinical Diagnostics

Mass spectrometry-based targeted proteomics workflows have within the last decade developed immensely in terms of automation, throughput and robustness – a prerequisite for implementation in the routine clinical biochemistry lab.

In this webinar, I will share my views on the challenges remaining ahead for implementing targeted protein assays as clinical lab tests, and provide examples of applications of MRM-based assays in arterial disease pathophysiology, diabetes and cancer follow-up diagnostics focusing on either multiplexing, high sensitivity or high specificity analysis.

Presenter: Martin Overgaard (Biochemist, Associate Professor, PhD, Department of Clinical Biochemistry Odense University Hospital, Odense, Denmark and Department of Clinical Research, SDU, University of Southern Denmark, Odense, Denmark)

Evosep Biosystems
LinkedIn Logo
 

Related content

Simultaneous Quantitation and Discovery analysis: Combining targeted and untargeted metabolomics on Orbitrap mass spectrometers

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Metabolomics

Analysis of Per- and Polyfluoroalkyl Substances (PFAS) in Wastewater

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Environmental

Non-Targeted Screening of Biosolids with the Xevo™ MRT Mass Spectrometer Reveals New Isoforms of PFAS

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Waters
Industries
Environmental

High Resolution Characterization of Lipid Nanoparticles Using the Xevo™ Charge Detection Mass Spectrometry (CDMS) Instrument - Single Particle Mass Analysis of Intact LNP-mRNA Formulations

Applications
| 2026 | Waters
Instrumentation
LC/MS, LC/MS/MS, LC/HRMS, Particle characterization, LC/IT
Manufacturer
Waters
Industries
Lipidomics

Out-of-the-box workflow for PFAS quantitation using a fullscan high-resolution approach with the Orbitrap Exploris EFOX Mass Detector

Applications
| 2025 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/Orbitrap, LC/HRMS
Manufacturer
Thermo Fisher Scientific
Industries
Environmental
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike